Ballentine Partners, LLC Zoetis Inc. Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q3 2024
A detailed history of Ballentine Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 11,794 shares of ZTS stock, worth $2.11 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
11,794
Previous 11,796
0.02%
Holding current value
$2.11 Million
Previous $2.04 Million
12.72%
% of portfolio
0.04%
Previous 0.04%
Shares
24 transactions
Others Institutions Holding ZTS
# of Institutions
1,923Shares Held
424MCall Options Held
1.15MPut Options Held
1.2M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.37 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.59 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$3.52 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.89 Billion2.53% of portfolio
-
Bank Of America Corp Charlotte, NC15.1MShares$2.7 Billion0.23% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $83.7B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...